1. Home
  2. NTNX vs SNN Comparison

NTNX vs SNN Comparison

Compare NTNX & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutanix Inc.

NTNX

Nutanix Inc.

HOLD

Current Price

$39.29

Market Cap

10.1B

Sector

Technology

ML Signal

HOLD

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$32.94

Market Cap

14.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTNX
SNN
Founded
2009
1856
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
14.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTNX
SNN
Price
$39.29
$32.94
Analyst Decision
Buy
Hold
Analyst Count
16
2
Target Price
$64.33
$36.25
AVG Volume (30 Days)
4.2M
841.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
2.28%
EPS Growth
227.45
N/A
EPS
0.57
N/A
Revenue
$2,537,927,000.00
N/A
Revenue This Year
$13.91
$7.19
Revenue Next Year
$13.28
$5.36
P/E Ratio
$68.49
$64.97
Revenue Growth
18.11
N/A
52 Week Low
$35.39
$23.91
52 Week High
$83.36
$38.79

Technical Indicators

Market Signals
Indicator
NTNX
SNN
Relative Strength Index (RSI) 44.11 37.60
Support Level $35.84 $32.08
Resistance Level $42.63 $33.89
Average True Range (ATR) 1.76 0.71
MACD 0.19 -0.44
Stochastic Oscillator 48.20 11.80

Price Performance

Historical Comparison
NTNX
SNN

About NTNX Nutanix Inc.

Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company operates a single operating and reportable segment based on a subscription business model. It conducts business in the United States, Europe, the Middle East and Africa, Asia Pacific, and other Americas, with key revenue generated from the United States.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: